A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

Cardiovascular Diabetology

Volumn 8, Issue , 2009, Pages

  Sibal, Latika ^a   Agarwal, Sharad C ^a   Schwedhelm, Edzard ^b   Lüneburg, Nicole ^b   Böger, Rainer H ^b   Home, Philip D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; N(G),N(G) DIMETHYLARGININE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; ARGININE; BIOLOGICAL MARKER; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE; NOS3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE; AMINO ACID BLOOD LEVEL; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BODY MASS; BRACHIAL ARTERY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROTEIN BLOOD LEVEL; ALBUMINURIA; BLOOD; CASE CONTROL STUDY; DRUG ANTAGONISM; ECHOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM; VASODILATATION;

ADOLESCENT; ADULT; ALBUMINURIA; ARGININE; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; RISK FACTORS; VASODILATION; YOUNG ADULT;

EID: 67650284549     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-8-27     Document Type: Article

References (37)

1. Chan NN Vallance P Colhoun HM Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: Role of conventional risk factors, sex, and glycemic control Arterioscler Thromb Vasc Biol 2003, 23:1048-1054. 10.1161/01.ATV.0000072968.00157.6B 12714434
2. Boger RH Bode-Boger SM Szuba A Tsao PS Chan JR Tangphao O Blaschke TF Cooke JP Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia Circulation 1998, 98:1842-1847. 9799202
3. Johnstone MT Creager SJ Scales KM Cusco JA Lee BK Creager MA Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus Circulation 1993, 88:2510-2516. 8080489
4. Boger RH Zoccali C ADMA: A novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease Atherosclerosis 2003, 4:23-28. 14664899
5. Surdacki A Nowicki M Sandmann J Tsikas D Boeger RH Bode-Boeger SM Kruszelnicka-Kwiatkowska O Kokot F Dubiel JS Froelich JC Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension J Cardiovasc Pharmacol 1999, 33:652-658. 10.1097/00005344-199904000-00020 10218738
6. Valkonen VP Paiva H Salonen JT Lakka TA Lehtimaki T Laakso J Laaksonen R Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 2001, 358:2127-2128. 10.1016/ S0140-6736(01)07184-7 11784629
7. Altinova AE Arslan M Sepici-Dincel A Akturk M Altan N Toruner FB Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations J Clin Endocrinol Metabol 2007, 92:1881-1885. 10.1210/jc.2006-2643
8. Heilman K Zilmer M Zilmer K Kool P Tillmann V Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes Scand J Clin Lab Invest 2008, 69:1-7.
9. McDermott JR Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit Biochem J 1976, 154:179-184. 1172690 1275907
10. Kimoto M Whitley GS Tsuji H Ogawa T Detection of NG, NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody J Biochem 1995, 117:237-238. 10.1093/jb/117.2.237 7608105
11. Vallance P Leone A Calver A Collier J Moncada S Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 1992, 339:572-575. 10.1016/0140-6736(92)90865-Z 1347093
12. Achan V Broadhead M Malaki M Whitley G Leiper J MacAllister R Vallance P Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase Arterioscler Thromb Vasc Biol 2003, 23:1455-1459. 10.1161/01.ATV.0000081742.92006.59 12805079
13. Creager MA Luscher TF Cosentino F Beckman JA Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I Circulation 2003, 108:1527-1532. 10.1161/ 01.CIR.0000091257.27563.32 14504252
14. Price DT Loscalzo J Cellular adhesion molecules and atherogenesis Am J Med 1999, 107:85-97. 10.1016/S0002-9343(99)00153-9 10403357
15. Thogersen AM Jansson JH Boman K Nilsson TK Weinehall L Huhtasaari F Hallmans G High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor Circulation 1998, 98:2241-2247. 9826309
16. Cosentino F Hishikawa K Katusic ZS Luscher TF High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells Circulation 1997, 96:25-28. 9236411
17. Ceriello A Postprandial hyperglycemia and diabetes complications: Is it time to treat? Diabetes 2005, 54:1-7. 10.2337/diabetes.54.1.1 15616004
18. Corretti MC Anderson TJ Benjamin EJ Celermajer D Charbonneau F Creager MA Deanfield J Drexler H Gerhard-Herman M Herrington D Vallance P Vita J Vogel R Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 2002, 39:257-265. 10.1016/S0735-1097(01)01746-6 11788217
19. Sidhu JS Newey VR Nassiri DK Kaski JC A rapid and reproducible on line automated technique to determine endothelial function Heart 2002, 88:289-292. 1767335 12181226 10.1136/heart.88.3.289
20. Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 1999, 130:461-470. 10075613
21. Schulze F Wesemann R Schwedhelm E Sydow K Albsmeier J Cooke JP Boger RH Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay Clin Chem Lab Med 2004, 42:1377-1383. 10.1515/CCLM.2004.257 15576299
22. Schulze F Maas R Freese R Schwedhelm E Silberhorn E Boger RH Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects Eur J Clin Invest 2005, 35:622-626. 10.1111/ j.1365-2362.2005.01561.x 16178881
23. Paiva H Lehtimaki T Laakso J Ruokonen I Rantalaiho V Wirta O Pasternack A Laaksonen R Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy Metabol: Clin Exp 2003, 52:303-307.
24. Kawano H Motoyama T Hirashima O Hirai N Miyao Y Sakamoto T Kugiyama K Ogawa H Yasue H Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery J Am Coll Cardiol 1999, 34:146-154. 10.1016/S0735-1097(99)00168-0 10400004
25. Wirta O Pasternack A Laippala P Turjanmaa V Glomerular filtration rate and kidney size after six years disease duration in non-insulin-dependent diabetic subjects Clin Nephrol 1996, 45:10-17. 8616951
26. MacAllister RJ Fickling SA Whitley GS Vallance P Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis Br J Pharmacol 1994, 112:43-48. 1910311 7518309
27. Tarnow L Hovind P Teerlink T Stehouwer CD Parving HH Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes Diabetes Care 2004, 27:765-769. 10.2337/diacare.27.3.765 14988299
28. Hink U Li H Mollnau H Oelze M Matheis E Hartmann M Skatchkov M Thaiss F Stahl RA Warnholtz A Meinertz T Griendling K Harrison DG Forstermann U Munzel T Mechanisms underlying endothelial dysfunction in diabetes mellitus Circ Res 2001, 88:E14-22. 11157681
29. Meininger CJ Marinos RS Hatakeyama K Martinez-Zaguilan R Rojas JD Kelly KA Wu G Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency Biochem J 2000, 349:353-356. 1221156 10861247 10.1042/ 0264-6021:3490353
30. Ozaki M Kawashima S Yamashita T Hirase T Namiki M Inoue N Hirata K Yasui H Sakurai H Yoshida Y Masada M Yokoyama M Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice J Clin Invest 2002, 110:331-340. 151086 12163452
31. Dixon LJ Hughes SM Rooney K Madden A Devine A Leahey W Henry W Johnston GD McVeigh GE Increased superoxide production in hypertensive patients with diabetes mellitus: Role of nitric oxide synthase Am J Hypertens 2005, 18:839-843. 10.1016/j.amjhyper.2005.01.004 15925745
32. Fasching P Veitl M Rohac M Streli C Schneider B Waldhausl W Wagner OF Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus J Clin Endocrinol Metabol 1996, 81:4313-4317. 10.1210/ jc.81.12.4313
33. Targher G Bertolini L Zoppini G Zenari L Falezza G Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy Diabet Med 2005, 22:999-1004. 10.1111/j.1464-5491.2005.01562.x 16026364
34. Pratte KA Baron AE Ogden LG Hassell KL Rewers M Hokanson JE Plasminogen activator inhibitor-1 is associated with coronary artery calcium in Type 1 diabetes J Diabetes Complications 2008. 18768333
35. Rohde LE Hennekens CH Ridker PM Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men Arterioscler Thromb Vasc Biol 1999, 19:1595-1599. 10397675
36. Chan JR Boger RH Bode-Boger SM Tangphao O Tsao PS Blaschke TF Cooke JP Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans Arterioscler Thromb Vasc Biol 2000, 20:1040-1046. 10764670
37. Boger RH Bode-Boger SM Tsao PS Lin PS Chan JR Cooke JP An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes J Am Coll Cardiol 2000, 36:2287-2295. 10.1016/ S0735-1097(00)01013-5 11127475